Acutaas Chemicals Ltd.

NSE: ACUTAAS | BSE: 543349 | ISIN: INE00FF01025 | Industry: Pharmaceuticals
| Expensive Star

4003.60
0.68%
Deven Choksey
Management reiterated its FY27 guidance of 25% revenue growth, with EBITDA margins expected to remain in line with FY26 levels. The company also maintains its long-term target of achieving INR 1,000 crore in CDMO revenue by FY28.
Acutaas Chemicals Ltd. has an average target of 2994.50 from 4 brokers.
More from Acutaas Chemicals Ltd.
Recommended